These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22502709)

  • 21. Circulating High-Molecular-Weight (HMW) Adiponectin Level Is Related with Breast Cancer Risk Better than Total Adiponectin: A Case-Control Study.
    Guo MM; Duan XN; Cui SD; Tian FG; Cao XC; Geng CZ; Fan ZM; Wang X; Wang S; Jiang HC; Zhang JG; Jin F; Tang JH; Liang H; Yang ZL; Wang HB; Wang QT; Li GL; Li L; Zhu SG; Zuo WS; Liu LY; Wang L; Ma DD; Liu SC; Xiang YJ; Liu L; Ye CM; Zhou WZ; Wang F; Yu LX; Ma ZB; Yu ZG
    PLoS One; 2015; 10(6):e0129246. PubMed ID: 26070203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Adiponectin Level Association with Breast Cancer Risk: Evidence from a Case-Control Study.
    Ahmed SD; Khanam A; Sultan N; Idrees F; Akhter N
    Asian Pac J Cancer Prev; 2015; 16(12):4945-8. PubMed ID: 26163619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum resistin is inversely related to breast cancer risk in premenopausal women.
    Georgiou GP; Provatopoulou X; Kalogera E; Siasos G; Menenakos E; Zografos GC; Gounaris A
    Breast; 2016 Oct; 29():163-9. PubMed ID: 27521488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of insulin resistance on adiponectin receptor expression in breast cancer.
    Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
    Maturitas; 2009 Jul; 63(3):253-6. PubMed ID: 19524379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
    Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
    J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiponectin and breast cancer risk.
    Mantzoros C; Petridou E; Dessypris N; Chavelas C; Dalamaga M; Alexe DM; Papadiamantis Y; Markopoulos C; Spanos E; Chrousos G; Trichopoulos D
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1102-7. PubMed ID: 15001594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.
    Petridou ET; Mitsiades N; Gialamas S; Angelopoulos M; Skalkidou A; Dessypris N; Hsi A; Lazaris N; Polyzos A; Syrigos C; Brennan AM; Tseleni-Balafouta S; Mantzoros CS
    Oncology; 2007; 73(3-4):261-9. PubMed ID: 18424891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between serum adiponectin and resistin levels, insulin resistance and colorectal adenomas.
    Demir N; Ahıshalı E; Dolapçıoğlu C; Ercan Ş; Orçun Kaptanağası A; Dabak R; Yücel N; Sargın M; Uygur Bayramiçli O
    Turk J Gastroenterol; 2015 Jan; 26(1):20-4. PubMed ID: 25698266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of serum adiponectin levels with breast cancer risk.
    Miyoshi Y; Funahashi T; Kihara S; Taguchi T; Tamaki Y; Matsuzawa Y; Noguchi S
    Clin Cancer Res; 2003 Nov; 9(15):5699-704. PubMed ID: 14654554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.
    Dalamaga M; Karmaniolas K; Panagiotou A; Hsi A; Chamberland J; Dimas C; Lekka A; Mantzoros CS
    Cancer Causes Control; 2009 Mar; 20(2):193-9. PubMed ID: 18814045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
    Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
    BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the relationship between serum adiponectin and insulin resistance in women with polycystic ovary syndrome].
    Yang XF; Ren FR; Guo SP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):261-3. PubMed ID: 16759463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
    Niraula S; Ocana A; Ennis M; Goodwin PJ
    Breast Cancer Res Treat; 2012 Jul; 134(2):769-81. PubMed ID: 22562122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin: Its role in obesity-associated colon and prostate cancers.
    Muppala S; Konduru SKP; Merchant N; Ramsoondar J; Rampersad CK; Rajitha B; Mukund V; Kancherla J; Hammond A; Barik TK; Mannarapu M; Alam A; Basha R; Bramhachari PV; Verma D; Sushma PS; Pattnaik S; Nagaraju GP
    Crit Rev Oncol Hematol; 2017 Aug; 116():125-133. PubMed ID: 28693794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association between serum leptin, adiponectin, visfatin, obesity and hypertension in female].
    Xia K; Ding R; Yang Y; Wu B; Zhang Q; Hu D
    Zhonghua Nei Ke Za Zhi; 2015 Sep; 54(9):768-72. PubMed ID: 26674794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.
    Inamura K; Song M; Jung S; Nishihara R; Yamauchi M; Lochhead P; Qian ZR; Kim SA; Mima K; Sukawa Y; Masuda A; Imamura Y; Zhang X; Pollak MN; Mantzoros CS; Harris CC; Giovannucci E; Fuchs CS; Cho E; Chan AT; Wu K; Ogino S
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between epidemiological features and tumor characteristics of breast cancer.
    Dogan L; Kalaylioglu Z; Karaman N; Ozaslan C; Atalay C; Altinok M
    Asian Pac J Cancer Prev; 2011; 12(12):3375-80. PubMed ID: 22471484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity, adipocytokines, and insulin resistance in breast cancer.
    Rose DP; Komninou D; Stephenson GD
    Obes Rev; 2004 Aug; 5(3):153-65. PubMed ID: 15245384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma adiponectin concentrations and risk of incident breast cancer.
    Tworoger SS; Eliassen AH; Kelesidis T; Colditz GA; Willett WC; Mantzoros CS; Hankinson SE
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1510-6. PubMed ID: 17213279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.